multi source·5h ago·5 sources analyzed
Trump signs order to expedite psychedelic drug reviews
The executive order aims to facilitate research on psychedelics for medical use. It specifically addresses drugs like ibogaine for conditions such as severe depression. (sources: fortune, aljazeera, nbcnews, foxnews, cspan)
Image: cspan
ModernAction Briefing
Trump signed an executive order directing the FDA to expedite the review of psychedelics designated as breakthrough therapy drugs. The order seeks to relax restrictions on these substances to promote research into their medical applications.
- The executive order focuses on psychedelics, including ibogaine, for potential medical treatments.
- The administration aims to ease restrictions to encourage research on these drugs.
- Trump was joined by Joe Rogan during the signing of the order.
Why it matters
This initiative could lead to increased research and potential therapeutic uses for psychedelics in treating mental health conditions.
No specific legislation identified for action yet.
Top coverage · 5 sources
fortuneTrump speeds review of psychedelics after Joe Rogan texted him about ibogaine. ‘Sounds great. Do you want FDA approval? Let’s do it’aljazeeraTrump joined by Joe Rogan as he signs order to speed up psychedelic reviewnbcnewsTrump jokes about asking for ibogaine at executive order signingfoxnewsTrump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs